Jessica Svedlund
Stockholm, AB 11363, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse.
Journal: Journal of translational medicine
Published: January 22, 2023
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.
Journal: Nature genetics
Published: October 28, 2021
Spatial genomics maps the structure, nature and evolution of cancer clones.
Journal: Nature
Published: April 21, 2021
OPENchip: an on-chip in situ molecular profiling platform for gene expression analysis and oncogenic mutation detection in single circulating tumour cells.
Journal: Lab on a chip
Published: February 15, 2020
Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer.
Journal: EBioMedicine
Published: March 21, 2019
Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
Journal: Journal of the National Cancer Institute
Published: November 22, 2017
Placing RNA in context and space - methods for spatially resolved transcriptomics.
Journal: The FEBS journal
Published: November 16, 2017
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.
Journal: Clinical chemistry
Published: September 01, 2017
Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer.
Journal: Cancer research
Published: July 20, 2016
The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Journal: Endocrine-related cancer
Published: December 03, 2013
In situ sequencing for RNA analysis in preserved tissue and cells.
Journal: Nature methods
Published: April 20, 2013
Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 01, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026